Organovo Non Current Liabilities Total vs Other Current Assets Analysis
ONVO Stock | USD 1.00 0.01 1.01% |
Organovo Holdings financial indicator trend analysis is much more than just breaking down Organovo Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Organovo Holdings is a good investment. Please check the relationship between Organovo Holdings Non Current Liabilities Total and its Other Current Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.
Non Current Liabilities Total vs Other Current Assets
Non Current Liabilities Total vs Other Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Organovo Holdings Non Current Liabilities Total account and Other Current Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Organovo Holdings' Non Current Liabilities Total and Other Current Assets is 0.42. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of Organovo Holdings, assuming nothing else is changed. The correlation between historical values of Organovo Holdings' Non Current Liabilities Total and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Organovo Holdings are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Non Current Liabilities Total i.e., Organovo Holdings' Non Current Liabilities Total and Other Current Assets go up and down completely randomly.
Correlation Coefficient | 0.42 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Non Current Liabilities Total
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Most indicators from Organovo Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Organovo Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.As of the 27th of April 2024, Selling General Administrative is likely to grow to about 14.4 M, while Tax Provision is likely to drop 1,710.
2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 142K | 293K | 263.7K | 250.5K | Research Development | 3.3M | 8.9M | 8.0M | 7.6M |
Organovo Holdings fundamental ratios Correlations
Click cells to compare fundamentals
Organovo Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Organovo Holdings fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 28.4M | 39.9M | 33.3M | 20.3M | 23.4M | 39.7M | |
Total Current Liabilities | 1.8M | 721K | 1.4M | 3.7M | 3.3M | 3.4M | |
Total Stockholder Equity | 26.6M | 39.2M | 30.2M | 15.3M | 17.6M | 34.6M | |
Net Debt | (27.4M) | (37.4M) | (26.5M) | (13.5M) | (12.1M) | (12.8M) | |
Retained Earnings | (279.5M) | (296.3M) | (307.7M) | (325.0M) | (292.5M) | (277.9M) | |
Accounts Payable | 720K | 281K | 415K | 331K | 380.7K | 588.6K | |
Cash | 27.4M | 37.4M | 28.7M | 15.3M | 17.6M | 16.7M | |
Cash And Short Term Investments | 27.4M | 37.4M | 28.7M | 16.0M | 18.4M | 36.2M | |
Common Stock Total Equity | 111K | 124K | 131K | 9K | 10.4K | 9.8K | |
Common Stock Shares Outstanding | 6.5M | 6.9M | 8.7M | 8.7M | 10.0M | 5.8M | |
Liabilities And Stockholders Equity | 28.4M | 39.9M | 33.3M | 20.3M | 23.4M | 39.7M | |
Other Current Assets | 851K | 1.0M | 858K | 889K | 1.0M | 882.9K | |
Other Stockholder Equity | 306.0M | 335.5M | 337.9M | 340.3M | 391.4M | 231.8M | |
Total Liab | 1.8M | 721K | 3.1M | 5.0M | 4.5M | 3.8M | |
Total Current Assets | 28.3M | 38.4M | 29.5M | 17.0M | 19.6M | 37.5M | |
Common Stock | 111K | 124K | 131K | 9K | 10.4K | 9.8K | |
Non Current Assets Total | 123K | 1.5M | 3.8M | 3.3M | 3.8M | 2.4M | |
Non Currrent Assets Other | 123K | 1.1M | 948K | 658K | 756.7K | 407.6K | |
Net Receivables | 558K | 111K | 0.0 | 152K | 136.8K | 226.8K | |
Non Current Liabilities Total | 720K | 281K | 1.7M | 1.3M | 1.5M | 1.6M | |
Property Plant And Equipment Gross | 415K | 381K | 3.9M | 3.9M | 4.5M | 2.3M | |
Other Current Liab | 1.1M | 440K | 489K | 2.8M | 2.6M | 2.9M | |
Property Plant And Equipment Net | 0.0 | 381K | 2.8M | 2.6M | 3.0M | 2.2M | |
Accumulated Other Comprehensive Income | (4.6M) | (415K) | 0.0 | 2K | 2.3K | 2.4K | |
Intangible Assets | 123K | 109K | 94K | 13K | 11.7K | 11.1K | |
Net Tangible Assets | 26.6M | 39.1M | 30.1M | 15.3M | 13.8M | 13.1M | |
Net Invested Capital | 26.6M | 39.2M | 30.2M | 15.3M | 13.8M | 25.6M | |
Net Working Capital | 26.5M | 37.7M | 28.2M | 13.4M | 12.0M | 11.4M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Organovo Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Organovo Holdings' short interest history, or implied volatility extrapolated from Organovo Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Organovo Stock analysis
When running Organovo Holdings' price analysis, check to measure Organovo Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organovo Holdings is operating at the current time. Most of Organovo Holdings' value examination focuses on studying past and present price action to predict the probability of Organovo Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organovo Holdings' price. Additionally, you may evaluate how the addition of Organovo Holdings to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Organovo Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share 0.027 | Quarterly Revenue Growth (0.96) | Return On Assets (0.73) | Return On Equity (1.34) |
The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.